{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:17:25Z","timestamp":1791605845126,"version":"4.3.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/med.0000000000000095","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T13:04:27Z","timestamp":1407416667000},"page":"323-329","source":"Crossref","is-referenced-by-count":201,"title":["Effects of metformin on weight loss"],"prefix":"10.1097","volume":"21","author":[{"given":"Steven K.","family":"Malin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta R.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20211004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults.","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"key":"R2-3-20211004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1503\/cjs.036111","article-title":"Biological effects of bariatric surgery on obesity-related comorbidities.","volume":"56","author":"Noria","year":"2013","journal-title":"Can J Surg"},{"key":"R3-3-20211004","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview.","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci"},{"key":"R4-3-20211004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2337\/dc09-0341","article-title":"Many Americans have prediabetes and should be considered for metformin therapy.","volume":"33","author":"Rhee","year":"2010","journal-title":"Diabetes Care"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in noninsulin-dependent diabetes mellitus.","volume":"333","author":"Stumvoll","year":"1995","journal-title":"N Engl J Med"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2337\/dc11-1299","article-title":"Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"R7-3-20211004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.diabet.2009.03.005","article-title":"Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in nondiabetic upper-body obese subjects with mild glucose anomalies: a posthoc analysis of the BIGPRO1 trial.","volume":"35","author":"Fontbonne","year":"2009","journal-title":"Diabetes Metab"},{"key":"R8-3-20211004","first-page":"27","article-title":"Effectiveness of metformin on weight loss in nondiabetic individuals with obesity.","volume":"121","author":"Seifarth","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R9-3-20211004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/oby.20235","article-title":"Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults.","volume":"21","author":"Malin","year":"2012","journal-title":"Obesity"},{"key":"R10-3-20211004","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"TODAY Study GroupA clinical trial to maintain glycemic control in youth with type 2 diabetes.","volume":"366","author":"Zeitler","year":"2012","journal-title":"N Engl J Med"},{"key":"R11-3-20211004","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1210\/jc.2012-4251","article-title":"Optimal macronutrient content of the diet for adolescents with prediabetes; RESIST a randomised control trial.","volume":"98","author":"Garnett","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-3-20211004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2012.02.021","article-title":"Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.","volume":"138","author":"Wang","year":"2012","journal-title":"Schizophr Res"},{"key":"R13-3-20211004","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1210\/jc.2013-4021","article-title":"Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study.","volume":"99","author":"Pau","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/j.1550-8528.1998.tb00314.x","article-title":"Metformin decreases food consumption and induces weight loss in subjects with obesity with type II noninsulin-dependent diabetes.","volume":"6","author":"Lee","year":"1998","journal-title":"Obes Res"},{"key":"R15-3-20211004","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-2004-821187","article-title":"Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels.","volume":"112","author":"Komori","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R17-3-20211004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2012.01.028","article-title":"The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats.","volume":"1444","author":"Lv","year":"2012","journal-title":"Brain Res"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000333963","article-title":"Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake.","volume":"96","author":"Stevanovic","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R19-3-20211004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4093\/dmj.2012.36.4.293","article-title":"Intracerebroventricular injection of metformin induces anorexia in rats.","volume":"36","author":"Lee","year":"2012","journal-title":"Diabetes Metab J"},{"key":"R20-3-20211004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/JME-09-0063","article-title":"AMPK as a mediator of hormonal signalling.","volume":"44","author":"Lim","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.metabol.2010.02.007","article-title":"The anorexigenic effects of metformin involve increases in hypothalamic leptin receptor expression.","volume":"60","author":"Aubert","year":"2011","journal-title":"Metabolism"},{"key":"R22-3-20211004","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/09513590902770172","article-title":"Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome.","volume":"25","author":"Billa","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"R23-3-20211004","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1152\/japplphysiol.00936.2012","article-title":"Effects of endurance exercise training, metformin, and their combination on adipose tissue leptin and IL-10 secretion in OLETF rats.","volume":"113","author":"Jenkins","year":"2012","journal-title":"J Appl Physiol"},{"key":"R24-3-20211004","first-page":"102","article-title":"Insulin and the brain.","volume":"9","author":"Derakhshan","year":"2013","journal-title":"Curr Diabetes Rev"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake.","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"R26-3-20211004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbrc.2012.02.109","article-title":"Possible involvement of melanocortin-4-receptor and AMP-activated protein kinase in the interaction of glucagon-like peptide-1 and leptin on feeding in rats.","volume":"420","author":"Poleni","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R27-3-20211004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/JOE-13-0272","article-title":"Role of the neural pathway from hindbrain to hypothalamus in interaction of GLP1 and leptin in rats.","volume":"220","author":"Akieda-Asai","year":"2014","journal-title":"J Endocrinol"},{"key":"R28-3-20211004","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1464-5491.2005.01461.x","article-title":"Inhibition of dipeptidyl peptidase IV activity by oral metformin in type 2 diabetes.","volume":"22","author":"Lindsay","year":"2005","journal-title":"Diabetic Med"},{"key":"R29-3-20211004","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1210\/en.2011-1485","article-title":"Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell.","volume":"152","author":"Mulherin","year":"2011","journal-title":"Endocrinology"},{"key":"R30-3-20211004","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","article-title":"Metformin and the intestine.","volume":"51","author":"Bailey","year":"2008","journal-title":"Diabetologia"},{"key":"R32-3-20211004","doi-asserted-by":"crossref","first-page":"E846","DOI":"10.1152\/ajpendo.00030.2008","article-title":"Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.","volume":"294","author":"Cervera","year":"2008","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"R33-3-20211004","doi-asserted-by":"crossref","first-page":"e91111","DOI":"10.1371\/journal.pone.0091111","article-title":"Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.","volume":"9","author":"Woo","year":"2014","journal-title":"PLoS One"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2337\/db10-0393","article-title":"Metformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity.","volume":"60","author":"Kim","year":"2011","journal-title":"Diabetes"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"E300","DOI":"10.1152\/ajpendo.00427.2013","article-title":"Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.","volume":"306","author":"Linden","year":"2013","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"R36-3-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4093\/dmj.2013.37.1.1","article-title":"AMPK and exercise: glucose uptake and insulin sensitivity.","volume":"37","author":"ONeill","year":"2013","journal-title":"Diabetes Metab J"},{"key":"R37-3-20211004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1123\/ijsnem.20.1.63","article-title":"Metformins effect on exercise and postexercise substrate oxidation.","volume":"20","author":"Malin","year":"2010","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1139\/apnm-2012-0433","article-title":"Effect of metformin on substrate utilization after exercise training in adults with impaired glucose tolerance.","volume":"38","author":"Malin","year":"2013","journal-title":"Appl Physiol Nutr Metab"},{"key":"R39-3-20211004","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1053\/meta.2002.50108","article-title":"Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal.","volume":"52","author":"Mathieu-Costello","year":"2003","journal-title":"Metabolism"},{"key":"R40-3-20211004","doi-asserted-by":"crossref","first-page":"E172","DOI":"10.1152\/ajpendo.00677.2006","article-title":"Metformin and exercise reduce muscle FATCD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.","volume":"293","author":"Smith","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R41-3-20211004","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/emm.2013.65","article-title":"AMP-activated protein kinase as a key molecular link between metabolism and clockwork.","volume":"45","author":"Lee","year":"2013","journal-title":"Exp Mol Med"},{"key":"R42-3-20211004","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/JES.0b013e3182a58a70","article-title":"Circadian rhythms, skeletal muscle molecular clocks, and exercise.","volume":"41","author":"Schroder","year":"2013","journal-title":"Exerc Sport Sci Rev"},{"key":"R43-3-20211004","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1463-1326.2011.01466.x","article-title":"Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese dbdb mice.","volume":"13","author":"Caton","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"R44-3-20211004","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bbadis.2012.08.005","article-title":"Metformin affects the circadian clock and metabolic rhythms in a tissue-specific manner.","volume":"1822","author":"Barnea","year":"2012","journal-title":"Biochim Biophys Acta"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201410000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T13:06:36Z","timestamp":1633525596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201410000-00003"}},"subtitle":["potential mechanisms"],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0000000000000095","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}